60 Degrees Pharmaceuticals, Inc.
SXTPW· Nasdaq
SXTPW60 Degrees Pharmaceuticals, Inc.
Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001213900-24-098195
| Metric | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|
| Revenue | $135.29K | $51.19K | $168.19K |
| Net Income | -$2.16M | $4.18M | -$1.45M |
| EPS Diluted | -$2.92 | $9.13 | -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end
